GlassScriptPhysician profile
Katherine Welsh
NPI 1770238321
$1,874.69
in general payments reported to CMS, 2019-2025
24 companies · $21.20 in 2025
The $21.20 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $816 · 2024: $1,037 · 2025: $21.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,874.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $309.52 | 2023-2024 | Provenge |
| Janssen Biotech, INC. | $268.84 | 2023-2024 | Erleada |
| Sumitomo Pharma America, INC. | $198.35 | 2023-2024 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $146.38 | 2024 | |
| Merck Sharp & Dohme LLC | $141.55 | 2023-2024 | Keytruda, Lynparza, Welireg |
| Progenics Pharmaceuticals, INC. | $106.04 | 2023-2024 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $87.20 | 2023-2024 | |
| Teleflex LLC | $78.40 | 2023-2024 | Urolift |
| Endo Pharmaceuticals INC. | $71.32 | 2023-2024 | Xiaflex |
| Coloplast Corp | $63.98 | 2023-2024 | Speedicath |
| Pfizer INC. | $55.69 | 2024 | |
| Antares Pharma, INC. | $51.16 | 2024 | Xyosted |
| Fujifilm Healthcare Americas Corporation | $38.46 | 2024 | Arietta Precision |
| Smith+Nephew, INC. | $31.76 | 2023 | Stravix |
| Civco Medical Instruments | $30.96 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $29.38 | 2023 | Gentlecath Glide |
| Blue Earth Diagnostics | $23.54 | 2024 | |
| Halozyme INC | $23.49 | 2023 | |
| Axonics, INC. | $22.41 | 2023 | Axonics |
| Medtronic, INC. | $21.20 | 2025 | Vitalflow Console |
| Astellas Pharma US INC | $20.73 | 2024 | Veozah |
| Endo USA, INC. | $18.92 | 2024 | Xiaflex |
| Sun Pharmaceutical Industries INC. | $18.11 | 2024 | |
| Ferring Pharmaceuticals INC. | $17.30 | 2024 | Adstiladrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Welsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.